Sofia Galinaki

Ms. Sofia Galinaki


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
KTKONSTANTINOS TSAMAKIS
KONSTANTINOS TSAMAKIS
SGSofia Galinaki
Sofia Galinaki
EAEvangelos Alevyzakis
Evangelos Alevyzakis
IHIoannis Hortis
Ioannis Hortis
DTDIMITRIOS TSIPTSIOS
DIMITRIOS TSIPTSIOS
EREmmanouil Rizos
Emmanouil Rizos
There is a growing body of evidence highlighting the role of gut microbiota as a biological basis of psychiatric disorders. The existing literature suggest that cognitive and emotional activities can be influenced by microbes through the microbiota–gut–brain axis and implies an association between alterations in the gut microbiome and several psychiatric conditions, such as autism, depression, bipolar disorder and psychosis. The aim of this review is to summarise recent findings and provide concise updates on the latest progress of the role of gut microbiota in the development and maintenance of psychiatric symptoms in schizophrenia and the first episode of psychosis. Despite the lack of consistent findings in regard to specific microbiome changes related to psychosis, the emerging literature reports significant differences in the gut microbiome of schizophrenic subjects compared to healthy controls and increasingly outlines the significance of an altered microbiome composition in the pathogenesis, development, symptom severity and prognosis of psychosis. Further human studies are, however, required, which should focus on identifying the drivers of microbiota changes in psychosis and establish the direction of causality between psychosis and microbiome alterations.